THE CHALLENGE OF

Administering Biologics

Chronic disease self-managed in the home with biologic-based therapies place the burden of drug administration on the patient, and can lead to disease management anxiety and less than optimal outcomes. Patient stress is compounded by the use of needle-based drug delivery devices to administer these medicines.

Needle anxiety, which is very different from needle-phobia, is a real concern. For many, having needles in the home is not desirable. Aside from the associated stigma around needle use, concerns include an innate dislike of needles, the inconvenience of disposing of needles and, safety around needle use which is especially worrisome when children live in the home.

Patients that switch to biologics want to administer their therapy successfully. Current modes of injection administration cause patient anxiety as it requires attention to detail, and can be painful especially as it requires the needle to be in the patient for 10-20 seconds to administer the complete dose. As a consequence, treatment adherence rates for biologics are less than optimal and thought to be in the 40% to 70% range depending on the indication [CDC, 2013; FDA 2016]. Some patients may even refuse a therapy if it requires needle-based self-injection.

THE TECHNOLOGY
  • Highly precise and accurate

  • Drug concentration and viscosity agnostic

  • Compatible with Pharma manufacturing processes

THE TRANSFORMED PATIENT EXPERIENCE
  • Needle-free: Greater safety and comfort 

  • Fast: Drug administration is over in half a second 

  • Connected technology provides customizable disease management tools

Pages of the Portal Instruments website may contain links to third party websites that are not under the control of Portal Instruments. Portal Instruments is not responsible for the content of any such site and the inclusion of these links does not imply the endorsement of the content of the linked site by Portal Instruments.